![]() |
市场调查报告书
商品编码
1916020
药用明胶市场规模、份额及成长分析(依产品类型、应用、原料、最终用户及地区划分)-2026-2033年产业预测Pharmaceutical Gelatin Market Size, Share, and Growth Analysis, By Product Type (Type A, Type B), By Application (Capsules, Tablets), By Source, By End-User, By Region - Industry Forecast 2026-2033 |
||||||
预计到 2024 年,全球药用明胶市场规模将达到 11.6 亿美元,到 2025 年将达到 12.2 亿美元,到 2033 年将达到 18.4 亿美元,预测期(2026-2033 年)的复合年增长率为 5.3%。
全球药用明胶市场正经历显着增长,主要受胶囊和明胶类药物需求不断增长的推动,而人口老化和慢性病流行是推动这一增长的主要因素。生物製药和疫苗的兴起,以及营养补充品产业的扩张,也促进了市场成长,这主要源自于消费者对易于消化吸收的药物剂型(如软胶囊和硬胶囊)的偏好日益增强。此外,药物研发和给药技术的进步也推动了产品组合的丰富化。然而,诸如对动物源性明胶的担忧、宗教和饮食限制以及对植物来源替代品的日益关注等挑战,以及其他因素,可能会阻碍更广泛的市场策略,并限制某些地区药用明胶的未来发展前景。
推动全球药用明胶市场发展的因素
全球药用明胶市场的主要驱动力是胶囊剂药物需求的不断增长。明胶胶囊因其易于吞嚥和生物利用度高,在处方药和非处方药中都发挥重要作用。消费者对明胶胶囊的日益增长的兴趣不仅满足了他们的偏好,也促进了市场的持续扩张。因此,药用明胶产业持续保持强劲成长,反映出医疗保健产业对明胶基解决方案的依赖性日益增强。这一趋势也印证了明胶在开发高效且患者友善的药物方面所扮演的重要角色。
限制全球药用明胶市场的因素
素食主义、纯素食主义和植物来源生活方式的兴起,导致人们对动物源明胶替代品的需求日益增长。这种转变在营养保健品和膳食补充剂领域尤其明显,植物来源胶囊日益增长的吸引力对传统明胶产品构成了重大挑战。在那些高度重视健康并关注动物产品伦理议题的市场中,这种转变尤其显着。因此,随着消费者越来越倾向于选择符合自身生活方式和价值观的植物来源解决方案,传统明胶正面临越来越大的压力,这正成为全球药用明胶市场的主要阻碍因素。
全球药用明胶市场趋势
受糖尿病、心血管疾病和关节炎等慢性疾病日益增多的推动,全球药用明胶市场正经历显着增长。随着医疗系统不断寻求有效的长期治疗方案,基于明胶的药物递送形式,尤其是软胶囊和明胶胶囊,因其便捷性和精准的剂量控制能力而需求激增。这种朝向更便于患者使用的给药方式的转变,不仅有助于提高患者的用药依从性,也拓展了明胶在各个治疗领域的应用,推动了市场发展。製药公司不断调整产品以满足全球患者不断变化的需求。
Global Pharmaceutical Gelatin Market size was valued at USD 1.16 Billion in 2024 and is poised to grow from USD 1.22 Billion in 2025 to USD 1.84 Billion by 2033, growing at a CAGR of 5.3% during the forecast period (2026-2033).
The global pharmaceutical gelatin market is experiencing significant growth, fueled by escalating demand for capsule and gelatin-based medications, driven largely by an increasing geriatric population and the prevalence of chronic diseases. The rise of biopharmaceuticals and vaccines, alongside the expanding nutraceutical sector, is further propelling market expansion, particularly as consumers show a preference for more easily digestible forms of medicine like soft gels and hard capsules. Additionally, advancements in pharmaceutical research and drug-delivery technologies are enhancing product offerings. However, challenges such as concerns regarding animal-derived gelatin, along with religious and dietary restrictions, coupled with a growing interest in plant-based alternatives, may inhibit broader market strategies and moderate the future outlook of pharmaceutical gelatin in various regions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Gelatin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Gelatin Market Segments Analysis
Global Pharmaceutical Gelatin Market is segmented by Product Type, Application, Source, End-User and region. Based on Product Type, the market is segmented into Type A and Type B. Based on Application, the market is segmented into Capsules, Tablets, Suppositories and Vaccines. Based on Source, the market is segmented into Porcine, Bovine and Fish. Based on End-User, the market is segmented into Pharmaceuticals, Nutraceuticals and Cosmetics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pharmaceutical Gelatin Market
The rising demand for pharmaceutical products in capsule form significantly propels the global pharmaceutical gelatin market. Gelatin capsules are favored for their ease of swallowing and ability to enhance bioavailability, making them crucial for both prescription and over-the-counter medications. This growing interest in gelatin encapsulation not only satisfies consumer preferences but also contributes to the ongoing expansion of the market. Consequently, the pharmaceutical gelatin sector continues to experience robust and consistent growth, reflecting the increasing reliance on gelatin-based solutions in the healthcare industry. This trend underscores the essential role of gelatin in developing effective and patient-friendly pharmaceutical products.
Restraints in the Global Pharmaceutical Gelatin Market
The rising trend towards veganism, vegetarianism, and plant-based living has led to an increased demand for alternatives to animal-derived gelatin. This shift is particularly evident in the nutraceuticals and dietary supplement sectors, where the growing appeal of plant-based capsules poses a significant challenge to conventional gelatin products. Such changes are especially pronounced in markets that prioritize health consciousness and consider ethical concerns surrounding animal products. Consequently, traditional gelatin faces mounting pressure as consumers increasingly seek out plant-derived solutions that align with their lifestyle choices and values, highlighting a critical restraint for the global pharmaceutical gelatin market.
Market Trends of the Global Pharmaceutical Gelatin Market
The global pharmaceutical gelatin market is experiencing notable growth driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular ailments, and arthritis. As healthcare systems increasingly seek effective long-term treatment solutions, the demand for gelatin-based drug delivery formats, particularly soft gel and gelatin capsules, has surged due to their convenience and precise dosing capabilities. This shift towards patient-friendly administration methods is not only enhancing medication adherence but also expanding the application of gelatin in various therapeutic areas, propelling the market forward as pharmaceutical companies adapt their offerings to meet the evolving needs of patients worldwide.